Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial

Björn Nashan, Peter Schemmer, Felix Braun, Hans J. Schlitt, Andreas Pascher, Christian G. Klein, Ulf P. Neumann, Irena Kroeger, Peter Wimmer, Hephaistos Study Group – 14 September 2021 – Everolimus‐facilitated reduced‐exposure tacrolimus (EVR + rTAC) at 30 days after liver transplantation (LT) has shown advantages in renal preservation. This study evaluated the effects of early initiation of EVR + rTAC in de novo LT recipients (LTRs).

Hepatology Highlights

Iman Waheed Khan, Muhammad Ashar Ali, Daryl T.Y. Lau, Thuy‐Van P. Hang, Preeti A. Reshamwala, Nidhi Jalan‐Sakrikar, Robert E. Schwartz, Shalil Khanal, Enis Kostallari, Anthony J. Choi, Robert S. Brown, Adebowale O. Bamidele, Davide Povero, Wei Zhang, Alyson Kaplan, Jeremy Louissaint, Nabeel Wahid, Jessica L. Maiers – 14 September 2021

The RNA binding protein human antigen R is a gatekeeper of liver homeostasis

Pallavi Subramanian, Sofia Gargani, Alessandra Palladini, Margarita Chatzimike, Michal Grzybek, Mirko Peitzsch, Anastasios D. Papanastasiou, Iryna Pyrina, Vasileios Ntafis, Bettina Gercken, Mathias Lesche, Andreas Petzold, Anupam Sinha, Marina Nati, Veera Raghavan Thangapandi, Ioannis Kourtzelis, Margarita Andreadou, Anke Witt, Andreas Dahl, Ralph Burkhardt, Robert Haase, António Miguel de Jesus Domingues, Ian Henry, Nicola Zamboni, Peter Mirtschink, Kyoung‐Jin Chung, Jochen Hampe, Ünal Coskun, Dimitris L. Kontoyiannis, Triantafyllos Chavakis – 13 September 2021

Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update

Luca Valenti, Serena Pelusi, Cristiana Bianco, Ferruccio Ceriotti, Alessandra Berzuini, Laura Iogna Prat, Roberta Trotti, Francesco Malvestiti, Roberta D’Ambrosio, Pietro Lampertico, Agostino Colli, Massimo Colombo, Emmanuel A. Tsochatzis, Mirella Fraquelli, Daniele Prati – 13 September 2021 – The changing epidemiology of liver disease, and modifications in the recommended analytical methodology call for a re‐evaluation of the upper reference limits (URLs) of alanine aminotransferase (ALT) levels.

Subscribe to